Forum Markets Incorporated (FRMM) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Special Meeting scheduled for October 7, 2025, to vote on eight key proposals, including director election, equity incentive plans, convertible note share issuance, and amendments to the certificate of incorporation.
Board unanimously recommends voting in favor of all proposals and emphasizes the importance of shareholder participation.
Proposals aim to enhance governance, incentivize management, and provide flexibility for future capital needs.
Voting matters and shareholder proposals
Election of Jason New as Class I director for a term expiring at the 2027 Annual Meeting.
Approval of the 2025 Omnibus Incentive Plan, 2025 Supplemental Option Incentive Plan, and 2025 Second Supplemental Option Incentive Plan.
Approval to remove the 20% cap on share issuance for convertible notes, potentially increasing dilution but providing capital flexibility.
Amendment to increase authorized common stock from 1 billion to 5 billion shares.
Amendments to remove obsolete provisions and clarify the certificate of incorporation.
Approval to adjourn the meeting if additional proxies are needed.
Board of directors and corporate governance
Board is divided into two classes with staggered terms; current leadership structure separates CEO and Chairman roles.
All board committees (Audit, Compensation, Nominating/Governance) are composed of independent directors.
Lead Independent Director role established to enhance independent oversight.
Board and committee charters, as well as the Code of Ethics, are available on the company website.
Latest events from Forum Markets Incorporated
- Tokenizing real-world assets on Ethereum unlocks high-yield, compliant investment opportunities.FRMM
Investor presentation20 Mar 2026 - Tokenizing real-world assets for yield, with rapid expansion and institutional focus.FRMM
Sidoti March Small-Cap Virtual Conference18 Mar 2026 - Tokenizing real-world assets for high-yield, compliant DeFi access and institutional adoption.FRMM
Investor presentation23 Jan 2026 - Registers 2.7M shares for resale amid DeFi expansion, ETH exposure, and high financial risk.FRMM
Registration Filing18 Dec 2025 - Registering 752,873 shares for resale as company pivots from biotech to blockchain iGaming.FRMM
Registration Filing16 Dec 2025 - Transitioning to blockchain iGaming, raising up to $500M for growth and strategic initiatives.FRMM
Registration Filing16 Dec 2025 - Shareholders to vote on director, equity plans, cap removal, and share increase proposals.FRMM
Proxy Filing2 Dec 2025 - Stockholders will vote on director elections, equity plan expansion, major stock issuances, and auditor ratification.FRMM
Proxy Filing2 Dec 2025 - Shareholders will vote on director elections, incentive plan expansion, major share issuances, and auditor ratification.FRMM
Proxy Filing2 Dec 2025